Optical imaging of treatment-related tumor cell death using a heat shock protein-90 alkylator

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3882-3891

  Park, Danielle ^a   Xie, Bang Wen ^b   Van Beek, Ermond R ^b   Blankevoort, Vicky ^b   Que, Ivo ^b   Löwik, Clemens W G M ^b   Hogg, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Chemotherapy; GSAO; Necrosis; Optical imaging; Tumor cell death

Indexed keywords

4 [N (S GLUTATHIONYLACETYL)AMINO]PHENYLARSONOUS ACID; BIOTIN; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; FLUORESCENT DYE; HEAT SHOCK PROTEIN 90; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL DEATH; CELL KILLING; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG EXCRETION; EX VIVO STUDY; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL LINE, TUMOR; CYCLOPHOSPHAMIDE; FEMALE; HSP90 HEAT-SHOCK PROTEINS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, NUDE;

EID: 84888368893     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp4003464     Document Type: Article

References (49)

1. Weber, W. A.; Czernin, J.; Phelps, M. E.; Herschman, H. R. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Nat. Clin. Pract. Oncol. 2008, 5 (1), 44-54.
2. Larson, S. M.; Schwartz, L. H. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology. J. Nucl. Med. 2006, 47 (6), 901-3.
3. Shankar, L. K.; Hoffman, J. M.; Bacharach, S.; Graham, M. M.; Karp, J.; Lammertsma, A. A.; Larson, S.; Mankoff, D. A.; Siegel, B. A.; Van den Abbeele, A.; Yap, J.; Sullivan, D. National Cancer, I. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J. Nucl. Med. 2006, 47 (6), 1059-66.
4. Workman, P.; Aboagye, E. O.; Chung, Y. L.; Griffiths, J. R.; Hart, R.; Leach, M. O.; Maxwell, R. J.; McSheehy, P. M.; Price, P. M.; Zweit, J. Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. J. Natl. Cancer Inst. 2006, 98 (9), 580-98.
5. Su, H.; Bodenstein, C.; Dumont, R. A.; Seimbille, Y.; Dubinett, S.; Phelps, M. E.; Herschman, H.; Czernin, J.; Weber, W. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin. Cancer Res. 2006, 12 (19), 5659-67.
6. Weissleder, R.; Pittet, M. J. Imaging in the era of molecular oncology. Nature 2008, 452 (7187), 580-9.
7. Johnstone, R. W.; Ruefli, A. A.; Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108 (2), 153-64.
8. Brown, J. M.; Attardi, L. D. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 2005, 5 (3), 231-7.
9. Kahlem, P.; Dorken, B.; Schmitt, C. A. Cellular senescence in cancer treatment: friend or foe? J. Clin. Invest. 2004, 113 (2), 169-74.
10. Schellenberger, E. A.; Bogdanov, A., Jr.; Petrovsky, A.; Ntziachristos, V.; Weissleder, R.; Josephson, L. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia 2003, 5 (3), 187-92.
11. Dechsupa, S.; Kothan, S.; Vergote, J.; Leger, G.; Martineau, A.; Berangeo, S.; Kosanlavit, R.; Moretti, J. L.; Mankhetkorn, S. Quercetin, Siamois 1 and Siamois 2 induce apoptosis in human breast cancer MDA-mB-435 cells xenograft in vivo. Cancer Biol. Ther. 2007, 6 (1), 56-61.
12. Beekman, C. A.; Buckle, T.; van Leeuwen, A. C.; Valdes Olmos, R. A.; Verheij, M.; Rottenberg, S.; van Leeuwen, F. W. Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer. Appl. Radiat. Isot. 2011, 69 (4), 656-62.
13. Lederle, W.; Arns, S.; Rix, A.; Gremse, F.; Doleschel, D.; Schmaljohann, J.; Mottaghy, F. M.; Kiessling, F.; Palmowski, M. Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects. EJNMMI Res. 2011, 1 (1), 26.
14. Wang, F.; Fang, W.; Zhao, M.; Wang, Z.; Ji, S.; Li, Y.; Zheng, Y. Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study. Nucl. Med. Biol. 2008, 35 (3), 359-64.
15. Zhao, M.; Beauregard, D. A.; Loizou, L.; Davletov, B.; Brindle, K. M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 2001, 7 (11), 1241-4.
16. Smith, B. A.; Akers, W. J.; Leevy, W. M.; Lampkins, A. J.; Xiao, S.; Wolter, W.; Suckow, M. A.; Achilefu, S.; Smith, B. D. Optical imaging of mammary and prostate tumors in living animals using a synthetic near infrared zinc(II)-dipicolylamine probe for anionic cell surfaces. J. Am. Chem. Soc. 2010, 132 (1), 67-9.
17. Smith, B. A.; Xiao, S.; Wolter, W.; Wheeler, J.; Suckow, M. A.; Smith, B. D. In vivo targeting of cell death using a synthetic fluorescent molecular probe. Apoptosis 2011, 16 (7), 722-31.
18. Xiong, C.; Brewer, K.; Song, S.; Zhang, R.; Lu, W.; Wen, X.; Li, C. Peptide-based imaging agents targeting phosphatidylserine for the detection of apoptosis. J. Med. Chem. 2011, 54 (6), 1825-35.
19. Nguyen, Q. D.; Smith, G.; Glaser, M.; Perumal, M.; Arstad, E.; Aboagye, E. O. Positron emission tomography imaging of druginduced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (38), 16375-80.
20. Al-Ejeh, F.; Darby, J. M.; Pensa, K.; Diener, K. R.; Hayball, J. D.; Brown, M. P. In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen. Clin. Cancer Res. 2007, 13 (18 Pt 2), 5519s-5527s.
21. Al-Ejeh, F.; Darby, J. M.; Tsopelas, C.; Smyth, D.; Manavis, J.; Brown, M. P. APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy. PloS One 2009, 4 (2), e4558.
22. Trepel, J.; Mollapour, M.; Giaccone, G.; Neckers, L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer 2010, 10 (8), 537-49.
23. Wandinger, S. K.; Richter, K.; Buchner, J. The Hsp90 chaperone machinery. J. Biol. Chem. 2008, 283 (27), 18473-7.
24. Lee, C. C.; Lin, T. W.; Ko, T. P.; Wang, A. H. The hexameric structures of human heat shock protein 90. PloS One 2011, 6 (5), e19961.
25. Nardai, G.; Sass, B.; Eber, J.; Orosz, G.; Csermely, P. Reactive cysteines of the 90-kDa heat shock protein, Hsp90. Arch. Biochem. Biophys. 2000, 384 (1), 59-67.
26. Park, D.; Don, A. S.; Massamiri, T.; Karwa, A.; Warner, B.; Macdonald, J.; Hemenway, C.; Naik, A.; Kuan, K. T.; Dilda, P. J.; Wong, J. W.; Camphausen, K.; Chinen, L.; Dyszlewski, M.; Hogg, P. J. Noninvasive imaging of cell death using an hsp90 ligand. J. Am. Chem. Soc. 2011, 133 (9), 2832-5.
27. Xie, B. W.; Park, D.; Van Beek, E. R.; Blankevoort, V.; Orabi, Y.; Que, I.; Kaijzel, E. L.; Chan, A.; Hogg, P. J.; Lowik, C. W. Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator. Cell Death Dis. 2013, 4, e473.
28. Donoghue, N.; Yam, P. T.; Jiang, X. M.; Hogg, P. J. Presence of closely spaced protein thiols on the surface of mammalian cells. Protein Sci. 2000, 9 (12), 2436-45.
29. Locasale, J. W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 2013, 13 (8), 572-83.
30. Xie, B. W.; Mol, I. M.; Keereweer, S.; van Beek, E. R.; Que, I.; Snoeks, T. J.; Chan, A.; Kaijzel, E. L.; Lowik, C. W. Dual-wavelength imaging of tumor progression by activatable and targeting nearinfrared fluorescent probes in a bioluminescent breast cancer model. PloS One 2012, 7 (2), e31875.
31. Scarlett, J. L.; Sheard, P. W.; Hughes, G.; Ledgerwood, E. C.; Ku, H. H.; Murphy, M. P. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett. 2000, 475 (3), 267-72.
32. Tafani, M.; Minchenko, D. A.; Serroni, A.; Farber, J. L. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res. 2001, 61 (6), 2459-66.
33. Sauter, B.; Albert, M. L.; Francisco, L.; Larsson, M.; Somersan, S.; Bhardwaj, N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000, 191 (3), 423-34.
34. Yang, T. J.; Haimovitz-Friedman, A.; Verheij, M. Anticancer therapy and apoptosis imaging. Exp. Oncol. 2012, 34 (3), 269-76.
35. Kietselaer, B. L.; Narula, J.; Hofstra, L. The Annexin code: revealing endocarditis. Eur. Heart J. 2007, 28 (8), 948.
36. Rouzet, F.; Dominguez Hernandez, M.; Hervatin, F.; Sarda-Mantel, L.; Lefort, A.; Duval, X.; Louedec, L.; Fantin, B.; Le Guludec, D.; Michel, J. B. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis. Circulation 2008, 117 (6), 781-9.
37. Balasubramanian, K.; Mirnikjoo, B.; Schroit, A. J. Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J. Biol. Chem. 2007, 282 (25), 18357-64.
38. Lin, S. H.; Vincent, A.; Shaw, T.; Maynard, K. I.; Maiese, K. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J. Cereb. Blood Flow Metab. 2000, 20 (9), 1380-91.
39. Yang, M. Y.; Chuang, H.; Chen, R. F.; Yang, K. D. Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J. Leukoc. Biol. 2002, 71 (2), 231-7.
40. Taylor, R. C.; Cullen, S. P.; Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9 (3), 231-41.
41. Porter, A. G.; Janicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999, 6 (2), 99-104.
42. Ayukawa, K.; Taniguchi, S.; Masumoto, J.; Hashimoto, S.; Sarvotham, H.; Hara, A.; Aoyama, T.; Sagara, J. La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis. J. Biol. Chem. 2000, 275 (44), 34465-70.
43. Aslakson, C. J.; Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52 (6), 1399-405.
44. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (8), 4607-12.
45. Singh, R. K.; Bucana, C. D.; Gutman, M.; Fan, D.; Wilson, M. R.; Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol. 1994, 145 (2), 365-74.
46. Kashiwagi, S.; Izumi, Y.; Gohongi, T.; Demou, Z. N.; Xu, L.; Huang, P. L.; Buerk, D. G.; Munn, L. L.; Jain, R. K.; Fukumura, D. NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest. 2005, 115 (7), 1816-27.
47. Roberts, W. G.; Delaat, J.; Nagane, M.; Huang, S.; Cavenee, W. K.; Palade, G. E. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am. J. Pathol. 1998, 153 (4), 1239-48.
48. Borgstrom, P.; Oh, P.; Czarny, M.; Racine, B.; Schnitzer, J. E. Co-implanting orthotopic tissue creates stroma microenvironment enhancing growth and angiogenesis of multiple tumors. F1000Research 2013, 2, 129; http://f1000research.com/articles/2-129/v1#sthash.nljEQQBV.dpuf.
49. Joensuu, H.; Gligorov, J. Adjuvant treatments for triple-negative breast cancers. Ann. Oncol. 2012, 23 (Suppl 6), vi40-5.